Discover 1,912 paid clinical trials in Fort Worth, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Fort Worth offers a range of medical research opportunities, focusing on conditions such as cancer, cardiovascular disease, PTSD, and COVID-19. Healthy volunteers looking for paid opportunities, as well as those with specific health concerns, can participate in studies at the city’s leading healthcare facilities, gaining access to new and innovative treatments while contributing to advancements in medical research.
Filter
2
Filter results
Results: 1,912
STOP AF First Post-Approval Study
for
Paroxysmal Atrial Fibrillation
Location: Dallas TX, Germantown TN, West Des Moines IA,
Sponsor: Medtronic Cardiac Ablation Solutions
Sex: All
Age: 18+
Code: NCT05227053
Recruiting
Clinical Trial on Agitation in Alzheimer's Dementia
for
Alzheimer Disease, Agitation,Psychomotor, Care Giving Burden,
Location: Dallas TX, Austin TX, Oklahoma City OK, Metairie LA,
Sponsor: IGC Pharma, LLC
Sex: All
Age: 60+
Code: NCT05543681
Phase2, Recruiting
The JULI Registry--Hemp and Cannabis Observational Registry
for
Chronic Pain, Appetite Disorders, Neuropathy,
Location: Dallas TX, Nashville TN, San Jose CA, Los Gatos CA
Sponsor: Juva Life
Sex: All
Age: 21+
Code: NCT04726254
Recruiting
Behavioral AI to Predict and Increase Peritoneal Dialysis Uptake
for
Chronic Kidney Disease
Location: Dallas TX
Sponsor: Scaled Insights
Sex: All
Age: 18+
Code: NCT06533254
Recruiting
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
Location: Dallas TX, Nashville TN, Boynton Beach FL, Glendale CA,
Sponsor: Neonc Technologies, Inc.
Sex: All
Age: 18+
Code: NCT06047379
Phase1, Phase2, Recruiting
The Hepatitis C Transplant Collaborative
for
Transplant; Failure, Heart, Hepatitis C
Location: Dallas TX
Sponsor: Baylor Research Institute
Sex: All
Age: 18+
Code: NCT04493385
Recruiting
A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
Location: Dallas TX, Pittsburgh PA, Fairfax VA, Boston MA
Sponsor: ImmVira Pharma Co. Ltd
Sex: All
Age: 18+
Code: NCT04370587
Phase1, Phase2, Recruiting
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
for
HER2-positive Gastric Cancer,
Location: Dallas TX, Webster TX, Santa Fe NM, St Louis MO,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06764875
Phase3, Recruiting
MDR - PMCF Study for Taperloc Complete Stems
for
Hip Arthritis, Hip Disease, Hip Fractures, Hip Injuries,